Abstract
Quantitative structure-activity relationship study was performed to understand the inhibitory activity of a set of 192 vascular endothelial growth factor receptor-2 (VEGFR-2) compounds. QSAR models were developed using multiple linear regression (MLR) and partial least squares (PLS) as linear methods. While principal component - artificial neural networks (PC-ANN) modeling method with application of eigenvalue ranking factor selection procedure was used as nonlinear method. The results obtained offer good regression models having good prediction ability. The results obtained by MLR and PLS are close and better than those obtained by principal component- artificial neural network. The best model was obtained with a correlation coefficient of 0.87. The strength and the predictive performance of the proposed models was verified using both internal (cross-validation and Y-scrambling) and external statistical validations.
Keywords: Vascular endothelial growth factor receptor-2 (VEGFR-2), quantitative structure-activity relationship, Principal component artificial neural network (PC-ANN), Multiple linear regression (MLR) and Partial least square (PLS), prediction ability, correlation coefficient, cross-validation, Y-scrambling
Current Pharmaceutical Design
Title:Exploring QSARs of Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2) Tyrosine Kinase Inhibitors by MLR, PLS and PC-ANN
Volume: 19 Issue: 12
Author(s): Omar Deeb, Sana Jawabreh and Mohammad Goodarzi
Affiliation:
Keywords: Vascular endothelial growth factor receptor-2 (VEGFR-2), quantitative structure-activity relationship, Principal component artificial neural network (PC-ANN), Multiple linear regression (MLR) and Partial least square (PLS), prediction ability, correlation coefficient, cross-validation, Y-scrambling
Abstract: Quantitative structure-activity relationship study was performed to understand the inhibitory activity of a set of 192 vascular endothelial growth factor receptor-2 (VEGFR-2) compounds. QSAR models were developed using multiple linear regression (MLR) and partial least squares (PLS) as linear methods. While principal component - artificial neural networks (PC-ANN) modeling method with application of eigenvalue ranking factor selection procedure was used as nonlinear method. The results obtained offer good regression models having good prediction ability. The results obtained by MLR and PLS are close and better than those obtained by principal component- artificial neural network. The best model was obtained with a correlation coefficient of 0.87. The strength and the predictive performance of the proposed models was verified using both internal (cross-validation and Y-scrambling) and external statistical validations.
Export Options
About this article
Cite this article as:
Deeb Omar, Jawabreh Sana and Goodarzi Mohammad, Exploring QSARs of Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2) Tyrosine Kinase Inhibitors by MLR, PLS and PC-ANN, Current Pharmaceutical Design 2013; 19 (12) . https://dx.doi.org/10.2174/1381612811319120010
DOI https://dx.doi.org/10.2174/1381612811319120010 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Tuberculosis Prevention, Diagnosis and Drug Discovery"
The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
Melanoma and Non-Melanoma Skin Cancer Treatment: Standard of Care and Recent Advances
In this thematic issue, we aim to provide a standard of care of the diagnosis and treatment of melanoma and non-melanoma skin cancer. The editor will invite authors from different countries who will write review articles of melanoma and non-melanoma skin cancers. The Diagnosis, Staging, Surgical Treatment, Non-Surgical Treatment all ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Searching for Therapeutics Against Botulinum Neurotoxins: A True Challenge for Drug Discovery
Current Topics in Medicinal Chemistry Computer Techniques for Drug Development from Thai Traditional Medicine
Current Pharmaceutical Design Synthesis of 4-(5-chloro-3-methyl-1-phenyl-1H-pyrazol-4-yl)-6-(substituted phenyl)pyrimidin-2-ol Analogues as Anti-Inflammatory and Analgesic Agents
Letters in Drug Design & Discovery Recent Progress on Bioinformatics, Functional Genomics, and Metabolomics Research of Cytochrome P450 and its Impact on Drug Discovery
Current Topics in Medicinal Chemistry Zinc Phosphate Nanoparticles: A Review on Physical, Chemical, and Biological Synthesis and their Applications
Current Pharmaceutical Biotechnology High-Content Screening and Mechanism-Based Evaluation of Estrogenic Botanical Extracts
Combinatorial Chemistry & High Throughput Screening Recent Advances in Azo Dye Degrading Enzyme Research
Current Protein & Peptide Science Oncogenic Properties of HIV-Tat in Colorectal Cancer Cells
Current HIV Research Neuroprotective Role of Natural Polyphenols
Current Topics in Medicinal Chemistry Achievements and Challenges of Proteomics in the Study of Rheumatoid Arthritis
Current Topics in Medicinal Chemistry Microarray and Nanotechnology Applications of Functional Nanoparticles
Combinatorial Chemistry & High Throughput Screening Recent Synthetic Strategies for Monocyclic Azole Nucleus and Its Role in Drug Discovery and Development
Current Organic Synthesis Electrochemical Sensors for Hydroperoxides Based on Prussian Blue
Current Analytical Chemistry Sonochemical Hot-spot Assisted One-pot Synthesis of 4-arylmethylidene - 2-phenyl-4H-oxazol-5-ones Using Nano-MgO as an Efficient Catalyst
Letters in Organic Chemistry The Impact of DIDS-Induced Inhibition of Voltage-Dependent Anion Channels (VDAC) on Cellular Response of Lymphoblastoid Cells to Ionizing Radiation
Medicinal Chemistry Amyloid Beta Peptide, 4-Hydroxynonenal and Apoptosis
Current Alzheimer Research NF-κB Down–regulation and PARP Cleavage by novel 3-α-butyryloxy-β-boswellic Acid Results in Cancer Cell Specific Apoptosis and in vivo Tumor Regression
Anti-Cancer Agents in Medicinal Chemistry Chemistry, Stability and Bioavailability of Resveratrol
Medicinal Chemistry HIV-1 Reactivation Induced by Apicidin Involves Histone Modification in Latently Infected Cells
Current HIV Research MAGNETIC CORE SHELL STRUCTURES: from 0D to 1D assembling
Current Pharmaceutical Design